Πλοήγηση ανά Θέμα "omalizumab"
Αποτελέσματα 1-5 από 5
-
Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes
(2021)The clinical phenotyping of severe asthma could improve treatment outcomes, quality of life, morbidity, and mortality of asthma patients. The growing availability of rich clinical data could provide opportunities to address ... -
Common variable immunodeficiency and asthma: Coexistence or coincidence?
(2020)[No abstract available] -
Effectiveness of autologous whole-blood injections in patients with refractory chronic spontaneous urticaria
(2017)Background: Nonsedating antihistamines are the treatment of choice for chronic spontaneous urticaria (CSU), while omalizumab and immunosuppressants have also been approved as an add-on treatment. Autologous whole-blood ... -
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
(2022)Background: At the beginning of the pandemic, there have been considerable concerns regarding coronavirus disease 2019 (COVID-19) severity and outcomes in patients with severe asthma treated with biologics. Objective: To ... -
Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
(2022)Introduction: The most clinically useful concept in asthma is based on the intensity of treatment required to achieve good asthma control. Biomarkers to guide therapy are needed. Aims: To investigate the role of circulating ...